Multifocal VEP and OCT in optic neuritis: a topographical study of the structure-function relationship.
OBJECTIVE
To investigate topographical relationship between amplitude of multifocal visual evoked potentials (mfVEP) and retinal nerve fibre layer (RNFL) thickness following acute optic neuritis (ON).


METHODS
Fifty patients with a clinical diagnosis of acute unilateral ON between 6 and 36 months prior to the study and 25 age-matched controls underwent mfVEP testing (Accumap V 2.1, ObjectiVision Pty Ltd, Sydney, Australia) and OCT imaging (fast RNFL protocol, Stratus, software version 3.0, Carl Zeiss Meditec, Inc., Dublin, CA). RNFL thickness and mfVEP amplitude were measured for upper, temporal and lower retinal sectors and corresponding areas of the visual field in affected eyes of ON patients and control eyes. Inter-eye asymmetry coefficients for both RNFL thickness and mfVEP amplitude were calculated for each zone, and corresponding coefficients were correlated between each other.


RESULTS
There was highly significant reduction of RNFL thickness and mean mfVEP amplitude in all three retinal sectors of the affected eye. Largest reduction of RNFL thickness was noticed in temporal sector and of mfVEP amplitude in corresponding central part of the visual field. RNFL thickness correlated highly with amplitude of the mfVEP derived from corresponding areas of the visual field in all three zones.


CONCLUSIONS
We demonstrated strong topographical associations between structural and functional measures of optic nerve integrity in patients with ON.
Klistorner
Alexander
A
Department of Ophthalmology, Save Sight Institute, University of Sydney, P.O. Box 4337, Sydney, NSW 2001, Australia. sasha@eye.usyd.edu.au
Arvind
H
H
Nguyen
T
T
Garrick
R
R
Paine
M
M
Graham
S
S
O'Day
J
J
Yiannikas
C
C
D000328:Adult; D005074:Evoked Potentials, Visual; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009412:Nerve Fibers / Q000473:pathology / Q000502:physiology; D009900:Optic Nerve / Q000473:pathology / Q000503:physiopathology; D009902:Optic Neuritis / Q000473:pathology / Q000503:physiopathology; D055351:Retinal Neurons / Q000473:pathology / Q000502:physiology; D041623:Tomography, Optical Coherence; D014794:Visual Fields / Q000502:physiology
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4549-56
17898277
Arch Neurol. 2006 Jun;63(6):847-50
16769865
Retina. 1994;14(5):445-51
7899721
Electroencephalogr Clin Neurophysiol. 1983 Apr;55(4):427-35
6187536
Arch Ophthalmol. 2003 Jul;121(7):944-9
12860795
Ann Neurol. 2005 Feb;57(2):210-5
15668965
Doc Ophthalmol. 2008 Jan;116(1):19-27
17680288
Brain. 2008 Jan;131(Pt 1):277-87
18056739
J Neurol. 1999 Sep;246(9):770-5
10525973
Ophthalmology. 2001 May;108(5):905-12
11320021
Am J Pathol. 2000 Jul;157(1):267-76
10880396
Neurology. 2007 May 1;68(18):1488-94
17470751
Brain. 2004 Nov;127(Pt 11):2498-505
15342363
Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2145-52
11481284
Ophthalmology. 2000 Dec;107(12):2283-99
11097611
Doc Ophthalmol. 2005 Nov;111(3):159-67
16523233
Ophthalmology. 2006 Feb;113(2):323.e1-323.e2
16406544
Arch Ophthalmol. 2005 Jun;123(6):729-39
15955974
N Engl J Med. 1998 Jan 29;338(5):278-85
9445407
Ann Neurol. 2005 Sep;58(3):383-91
16075460
J Glaucoma. 2006 Apr;15(2):110-6
16633223
Prog Retin Eye Res. 2000 Sep;19(5):607-46
10925245
Brain. 1991 Dec;114 ( Pt 6):2437-50
1782525
Doc Ophthalmol. 2004 Sep;109(2):189-99
15881265
Ophthalmology. 2000 Oct;107(10):1809-15
11013178
Invest Ophthalmol Vis Sci. 2000 May;41(6):1580-7
10798679
J Neurol Sci. 2007 Dec 15;263(1-2):3-14
17673257
Ann Neurol. 2005 Jun;57(6):904-13
15929047
Ann Neurol. 2001 Jul;50(1):121-7
11456302
Ann Neurol. 2005 May;57(5):622-33
15852380
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2520-7
10509645
Curr Opin Ophthalmol. 2005 Dec;16(6):346-50
16264344
Eur J Neurol. 2007 Aug;14(8):841-9
17662003
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2440-3
15980233
Br J Ophthalmol. 2003 Jul;87(7):899-901
12812895
Am J Ophthalmol. 2002 Jan;133(1):29-39
11755837
Brain. 2005 Nov;128(Pt 11):2705-12
16230320
Curr Opin Ophthalmol. 1999 Apr;10(2):140-6
10537765
J Neurol. 2005 Nov;252 Suppl 5:v16-24
16254697
Neuroimage. 2006 May 15;31(1):286-93
16446103
J Glaucoma. 2000 Feb;9(1):10-9
10708226
Invest Ophthalmol Vis Sci. 1998 May;39(6):937-50
9579473
Brain. 2001 Sep;124(Pt 9):1813-20
11522583
Arch Neurol. 2008 Jan;65(1):26-35
18195137
Acta Ophthalmol Scand. 2006 Dec;84(6):790-4
17083540
Ophthalmology. 2006 Feb;113(2):324-32
16406539
Electroencephalogr Clin Neurophysiol. 1994 Jan;90(1):65-81
7509275
Neurology. 1995 Feb;45(2):244-50
7854520
J Neurol Sci. 2003 Feb 15;206(2):193-8
12559510
J Physiol. 1961 Dec;159:203-21
13883391
Curr Neurol Neurosci Rep. 2007 May;7(3):239-44
17488590
Invest Ophthalmol Vis Sci. 2000 Nov;41(12):4032-8
11053309
Ann Neurol. 2006 Jun;59(6):963-9
16718705
Invest Ophthalmol Vis Sci. 1977 Sep;16(9):841-9
408291
Aust N Z J Ophthalmol. 1998 May;26 Suppl 1:S91-4
9685035
Invest Ophthalmol Vis Sci. 2004 Feb;45(2):492-8
14744890